(0.05%) 5 310.73 points
(0.08%) 39 940 points
(0.01%) 16 745 points
(0.78%) $79.24
(3.10%) $2.49
(-0.44%) $2 384.40
(0.44%) $29.86
(-0.20%) $1 068.00
(0.15%) $0.920
(0.27%) $10.69
(0.08%) $0.789
(0.16%) $90.83
@ $1.570
Issued: 13 Feb 2024 @ 16:00
Return: -45.97%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: -2.45 %
Live Chart Being Loaded With Signals
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain...
Stats | |
---|---|
Today's Volume | 348 344 |
Average Volume | 1.03M |
Market Cap | 153.69M |
EPS | $0 ( 2024-05-10 ) |
Next earnings date | ( $-0.110 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.650 |
ATR14 | $0.00200 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-22 | Ma Stephen Hoi | Sell | 0 | Common Stock |
2023-10-04 | Ji Henry | Buy | 200 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Shah Jaisim | Buy | 200 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Wu Yue Alexander | Buy | 250 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Chun Jay | Buy | 250 000 | Nonstatutory Stock Option (right to buy) |
INSIDER POWER |
---|
-85.66 |
Last 48 transactions |
Buy: 17 843 347 | Sell: 160 710 385 |
Volume Correlation
Scilex Holding Company Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Scilex Holding Company Correlation - Currency/Commodity
Scilex Holding Company Financials
Annual | 2023 |
Revenue: | $46.74M |
Gross Profit: | $26.92M (57.58 %) |
EPS: | $-0.880 |
FY | 2023 |
Revenue: | $46.74M |
Gross Profit: | $26.92M (57.58 %) |
EPS: | $-0.880 |
FY | 2022 |
Revenue: | $38.03M |
Gross Profit: | $27.24M (71.61 %) |
EPS: | $-0.170 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators